High Times
Home > Boards > US Listed > Medical - Equipment >

InspireMD, Inc. (NSPR)

NSPR RSS Feed
Add NSPR Price Alert      Hide Sticky   Hide Intro
Moderator: Value_Investor
Search This Board: 
Last Post: 10/19/2018 12:29:49 PM - Followers: 84 - Board type: Free - Posts Today: 0

Great Europe-Patent News for NSPR (01.05.2017):
 https://register.epo.org/application?number=EP07827415

NSPR is still one of the Cheapest NYSE stocks based on the New BV & CV! The 10-Q confirms its 100% Debt-Free financial status which is the most important fundamental for a big board stock ! 

https://register.epo.org/application?number=EP07827415 
https://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-113000992.html 
http://finance.yahoo.com/news/inspiremd-announces-distribution-agreement-cguard-110000931.html 
http://finance.yahoo.com/news/inspiremd-cguard-tm-embolic-prevention-133200180.html 
http://www.marketwatch.com/story/inspiremd-repays-term-note-ahead-of-schedule-2017-03-22?siteid=bigcharts&dist=bigcharts 


InspireMD was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes.

Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures.
 

Our Technology

MicroNetTM

The MicroNet is a bio-stable mesh woven from a single strand of 20 μm Polyethylene Terephthalate (PET). The MicroNet is designed to trap and seal thrombus and plaque against the vessel wall, preventing embolization.

MicroNetTM key features:

  • PET is a bio-stable synthetic fiber widely used in a variety of industries.
    Attached and secured to the proximal and the distal crowns of the stent.
    Does not alter the procedure as it expands with the stent.
    Pore size is typically between 150 – 180 µm. 
     

CGuard™

need for tapered version


Carotid Embolic Prevention System

The CGuardTM Embolic Prevention System (EPS) is designed to prevent peri-procedural and late embolization by trapping potential emboli against the arterial wall while maintaining excellent perfusion to the external carotid artery and branch vessels.

Product Details:

  • CGuard material: Nitinol
MicroNet material: Polyethylene Terephthalate (PET)
  • Easy to use RX (Rapid Exchange) delivery system
     

MGuard™

Improving Clinical Outcomes For STEMI Patients

The MGuardTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization and optimize flow.

While offering performance that is superior to standard STEMI therapy, MGuard requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard material: Stainless Steel 316 
  • MicroNet material: Polyethylene Terephthalate (PET)

     

MGuard Prime™

Improving Clinical Outcomes For STEMI Patients

The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM  (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.

While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.

 

Product Details:

  • MGuard Prime material: Cobalt Chromium (CoCr) L605

MicroNet material: Polyethylene Terephthalate (PET)
  • Superior flexibility and excellent deliverability

http://www.inspiremd.com/en/products/the-technology/
 

2017 News

Thursday23March 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at ICCA Stroke 2017 in Moscow, Russia

BOSTON, MA—March 23, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced that its…

Wednesday22March 2017

InspireMD Repays Term Note Ahead of Schedule

Tel Aviv—March 22, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that…

Tuesday21March 2017

InspireMD Announces Distribution Agreement for CGuard™ EPS in Hong Kong

BOSTON, MA—March 21, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Monday20March 2017

InspireMD Announces CGuardTM Distribution Agreement for the Russian Federation

Tel Aviv—March 20, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it…

Wednesday15March 2017

InspireMD Reports Continued Progress in the Transition of European Sales and Distribution

Announces Agreements with Leading Distributors in the Baltic States   BOSTON, MA—March 15, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS)…

Tuesday14March 2017

InspireMD Announces Closing of Public Offering of Approximately $6.8 Million

BOSTON, MA – March 14, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday09March 2017

InspireMD Announces Pricing of Public Offering of up to $7.5 Million

BOSTON, MA – March 9, 2017 – InspireMD, Inc. (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices,…

Thursday16February 2017

InspireMD Provides Year End Business Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016

Transition from Exclusive Distribution Partner to Local Distributors and Internal Sales Strategy Validated by Strong Revenue Growth in Select Markets   BOSTON, MA—February 16, 2017 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS)…

Tuesday24January 2017

InspireMD’s CGuard™ Carotid Embolic Prevention System to be Featured at LINC 2017

PD Dr. Andrej Schmidt to perform live case transmission of carotid stent surgery utilizing CGuard™ BOSTON, MA– January 24, 2016 – InspireMD, Inc. (NYSE MKT:NSPR) (NYSE MKT:NSPR.WS) (“InspireMD” or the “Company”), a…

Contact Us

Thank you for your interest in InspireMD, please let us know how we can help you. You can contact us at info@inspiremd.com or 1-888-776-6804.

Executives

James J. BarryPresident & Chief Executive Officer

Dr. Barry has over 20 years of experience in the medical device industry. Prior to joining InspireMD, he was the President and CEO of Arsenal Medical, a life sciences company…

Craig ShoreChief Financial Officer

Mr. Shore has over 25 years of experience in financial management in the United States, Europe and Israel. He has served in various senior financial and general management roles at…

Agustin GagoExecutive Vice President and Chief Commercial Officer

Mr. Gago has over 25 years of experience in building profitable international commercial, sales and marketing organizations. Prior to joining InspireMD, he was the founder and principal of Dash International…

Benzi SpectorHead of R&D and Operations

Mr. Spector has more than 25 years of experience in research, development and engineering, serving as the lead on a range of product lines and systems in the healthcare space….

Sharon ShacharHead of Regulatory and Quality

Mrs. Shachar has over 12 years of experience in quality, regulatory and clinical execution, serving in executive roles in small and large medical companies.   Prior to joining InspireMD, she…

Website:  http://www.inspiremd.com/en/

 

High Times
NSPR
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
#1907   Lots of shares being bought, but lots of 420man 10/18/18 03:54:19 PM
PostSubject
#1889  Sticky Note Why today's good news brought the price down, Value_Investor 10/09/18 11:58:23 AM
#1911   NSPR declined to $0.231 so far from this Value_Investor 10/19/18 12:29:49 PM
#1910   investorshub.advfn.com/uimage/uploads/2018/10/19/pnfgwNSPR-D.png NYK PT 10/19/18 02:57:15 AM
#1909   Tens Of Thousands shares Slapped at $0.28 ~ Value_Investor 10/18/18 10:04:14 PM
#1908  Restored * * $NSPR Video Chart 10-18-18 * * ClayTrader 10/18/18 05:48:26 PM
#1907   Lots of shares being bought, but lots of 420man 10/18/18 03:54:19 PM
#1906   investorshub.advfn.com/uimage/uploads/2018/10/18/upzjfNSPR-D.png NYK PT 10/18/18 11:21:35 AM
#1905   appears to be making a move , time Timing101 10/18/18 10:53:29 AM
#1904   watch the charts next time Timing101 10/18/18 10:52:34 AM
#1903   NOW 420man 10/18/18 10:51:18 AM
#1902   NSPR hit another New low $0.205 yesterday! We Value_Investor 10/18/18 10:28:30 AM
#1901   I believe we will not break the .20xx NYK PT 10/18/18 03:31:08 AM
#1900   NSPR hit another New low $0.2131 so far! Value_Investor 10/17/18 11:35:13 AM
#1899   Can't believe this couldn't hold over 25c once Three2001 10/16/18 10:36:39 AM
#1898   $0.2139 was yesterday's New low. I bet those Value_Investor 10/16/18 10:06:57 AM
#1897   $NSPR Surviving the ride on the 20 day 612rat 10/15/18 08:49:32 PM
#1896   Wow, total 1,967,400 shares were shorted as of Value_Investor 10/15/18 02:50:24 PM
#1895   Another New low $0.219 ~ $0.217 today! NSPR Value_Investor 10/12/18 04:50:07 PM
#1894   NSPR declined to $0.2201 yesterday! I'm wondering if Value_Investor 10/12/18 09:48:20 AM
#1893   $0.162 was a New bottom support for NSPR Value_Investor 10/11/18 10:50:15 AM
#1892   $0.223 hit today! What is wrong with yesterday's Value_Investor 10/10/18 04:18:33 PM
#1890   At least to say the least! Three2001 10/09/18 12:01:04 PM
#1889   Why today's good news brought the price down, Value_Investor 10/09/18 11:58:23 AM
#1888   I'm willing to sell all my 5M shares Value_Investor 10/05/18 11:06:43 AM
#1886   $0.162 is a good price to get in Value_Investor 10/04/18 08:21:44 PM
#1885   NSPR heavily undervalued. $3 stock atleast. rancher64 10/04/18 10:25:42 AM
#1884   Bring it, I'm out today and ready to John_Langston 10/03/18 10:57:24 PM
#1883   * * $NSPR Video Chart 10-03-18 * * ClayTrader 10/03/18 06:06:23 PM
#1882   .24 $pennypuppet 10/03/18 02:29:48 PM
#1881   we sure do its pivot which was .23-.24 $pennypuppet 10/03/18 02:29:36 PM
#1880   I think we have a new support rdsmalltimeinvestor 10/03/18 12:24:11 PM
#1879   I think itll bounce on the open rdsmalltimeinvestor 10/03/18 11:34:29 AM
#1878   Yes, NSPR will soon crash back to its Value_Investor 10/03/18 11:33:15 AM
#1877   Rsi hovers just above 30 right now so oversold rdsmalltimeinvestor 10/03/18 11:22:44 AM
#1876   Bears taking over and its annoying rdsmalltimeinvestor 10/03/18 11:21:58 AM
#1875   Time to Fly. Approval in US by Q2 2019? rancher64 10/03/18 10:23:15 AM
#1874   Wont go higher than 0.31 IMO once it Makk1 10/03/18 09:16:19 AM
#1873   investorshub.advfn.com/uimage/uploads/2016/6/15/myrndLWtears.jpg John_Langston 10/03/18 09:10:54 AM
#1872   Nice call John_Langston 10/03/18 09:09:30 AM
#1871   I see a push to .4 with a clouts021 10/03/18 09:05:09 AM
#1870   >>> I stand correct here again >>> Makk1 10/03/18 09:00:01 AM
#1869   I do consider the offering, I just dont Makk1 10/03/18 03:10:03 AM
#1868   NSPR declined to $0.1951 today! The current OS Value_Investor 10/02/18 08:47:48 PM
#1867   NSPR is on fire today! Last week's high Value_Investor 10/02/18 12:20:55 PM
#1866   Nobody is considering that there's an active offering RamiroGaliza 10/02/18 02:09:07 AM
#1865   Well, if that were a "Good News" as Value_Investor 10/01/18 06:59:41 PM
#1864   Just took a nice position here! Have had clouts021 10/01/18 05:10:57 PM
#1863   Will retest 0.3 this week. Makk1 10/01/18 10:14:06 AM
#1862   That bad news already crashed NSPR to $0.20 Value_Investor 10/01/18 10:02:23 AM
#1861   Disagree that news of CCO departure is to Makk1 09/30/18 01:49:26 AM
#1860   So I really wish some very good news John_Langston 09/29/18 05:47:06 PM
PostSubject